calendar
4,370 catalysts · 3,230 8k filing · 577 earnings · 184 grant · 172 phase 2 completion · 133 drug shortage · 128 approval
next 91 dayslessmore
MonWedFri
4,370 catalysts · 3,230 8k filing · 577 earnings · 184 grant · 172 phase 2 completion · 133 drug shortage · 128 approval
Items: 7.01, 8.01, 9.01
Items: 3.02, 9.01
Items: 2.02, 9.01
Items: 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, 9.01
Items: 2.02, 7.01
Items: 5.02
Items: 2.02, 9.01
Items: 8.01, 9.01
Items: 5.02, 9.01
Items: 8.01
Items: 5.02
Items: 7.01, 9.01
Items: 7.01, 9.01
Items: 5.02
Items: 5.02
Items: 8.01
Items: 2.02, 9.01
Items: 1.01
Items: 5.02
Items: 3.01
Items: 1.01, 3.02, 5.01, 5.02, 5.03, 5.07, 9.01
Items: 3.01, 7.01, 9.01
Items: 8.01, 9.01
Therapy area: Metabolic Disorders. Indication: Type 1 Diabetes (Juvenile Diabetes)
Therapy area: Oncology. Indication: Hepatocellular Carcinoma, Liver Cancer
Therapy area: Oncology. Indication: Cervical Cancer, Colorectal Cancer, Cutaneous Squamous Cell Carcinoma (cSCC), Esophageal Cancer, Esophageal Squamous Cell Carcinoma (ESCC), Gastric Cancer, Head And Neck Cancer, Head And Neck Squamous Cell Carcinoma (HNSC), Hepatocellular Carcinoma, Hypopharyngeal Cancer, Laryngeal Cancer, Malignant Pleural Mesothelioma, Melanoma, Non-Small Cell Lung Carcinoma, Oral Cancer, Oral Cavity (Mouth) Cancer, Oropharyngeal Cancer, Ovarian Cancer, Pancreatic Cancer, Re
Therapy area: Cardiovascular. Indication: Cerebrovascular Disease, Ischemia
Therapy area: Hematological Disorders. Indication: Hemophilia A (Factor VIII Deficiency)
Therapy area: Oncology. Indication: Breast Cancer, Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer), Metastatic Breast Cancer
Therapy area: Infectious Disease. Indication: Coronavirus Disease 2019 (COVID-19)
Therapy area: Metabolic Disorders. Indication: Phenylketonuria (PKU)
Therapy area: Cardiovascular. Indication: Ischemic Stroke
Therapy area: Oncology. Indication: Multiple Myeloma (Kahler Disease), Plasma Cell Neoplasm, Refractory Multiple Myeloma, Relapsed Multiple Myeloma
Therapy area: Nutritional Disorders. Indication: Unspecified Nutritional Disorders
Therapy area: Ophthalmology. Indication: Cataract, Fuchs Endothelial Corneal Dystrophy (FECD)
Therapy area: Gastrointestinal, Genetic Disorders, Hematological Disorders, Respiratory. Indication: Cytopenia, Liver Fibrosis, Mutational Disorders, Pulmonary Fibrosis
Therapy area: Infectious Disease, Mouth and Dental Disorders. Indication: Periodontitis, Unspecified Infectious Diseases
Therapy area: Dermatology. Indication: Vitiligo
Therapy area: Women's Health. Indication: Menorrhagia
Therapy area: Immunology. Indication: Kidney Transplant Rejection
Therapy area: Cardiovascular. Indication: Hypotension
Therapy area: Immunology. Indication: Cutaneous Lupus Erythematosus, Systemic Lupus Erythematosus
Therapy area: Gastrointestinal, Genito Urinary System, Infectious Disease. Indication: Gonorrhea, Intestinal Infection, Salmonella Infections, Typhoid Fever, Urinary Tract Infections
Therapy area: Central Nervous System. Indication: Post-Operative Pain
Therapy area: Oncology. Indication: Multiple Myeloma (Kahler Disease), Refractory Multiple Myeloma
Therapy area: Oncology, Toxicology. Indication: Chemotherapy Induced Acral Erythema (Hand-Foot Syndrome), Colon Tumor
Therapy area: Respiratory. Indication: Idiopathic Pulmonary Fibrosis, Interstitial Lung Fibrosis
Therapy area: Infectious Disease. Indication: Hepatitis B
Therapy area: Oncology. Indication: Hormone-Sensitive Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer (mCRPC), Metastatic Prostate Cancer, Prostate Cancer
Therapy area: Gastrointestinal. Indication: Irritable Bowel Syndrome